$8.98 0.21 (+2.39%)
11/6/2009 4:00 PM

Enzon Pharmaceuticals, Inc. (ENZN)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Current Price $8.98 Mkt Cap $408.19M
Open $8.69 P/E Ratio 438.50
Prev. Close $8.77 Div. (Yield) N/A (N/A)
Daily Range $8.68 - $9.04 Volume 361,729
52-Wk Range $2.95 - $9.32 Avg. Daily Vol. 856,000

ENZN News and Commentary

Caps

How do you think ENZN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

93 Outperform
10 Underperform
 

All-Star Members

27 Outperform
3 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top ENZN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

LarkinSoft (99.68)
Submitted October 09, 2006

Nearly 100% of the stock is in the hands of institutional traders, all purchased near the bottom. Riding the smart money's coattails is a sure winner. This stock will double within 24 months.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

ENZN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about ENZN.

Recs

0
Member Avatar spundun (68.07) Submitted: 10/8/2009 7:38:46 PM : Outperform Start Price: $8.58 ENZN Score: +4.20

UL predicting a buyout by wellpoint

Recs

0
Member Avatar healthcare1 (< 20) Submitted: 1/17/2009 5:04:27 AM : Outperform Start Price: $6.23 ENZN Score: +14.70

it has a unique drug delivery system and activist shareholders

Recs

0
Member Avatar mjan706 (< 20) Submitted: 9/22/2008 1:44:10 AM : Outperform Start Price: $7.89 ENZN Score: +25.60

An Icahn portfolio stock.

Leaderboard

Find the members with the highest scoring picks in ENZN.

Score Leader

EMBitzy

EMBitzy (60.14) Score: +70.28

The Score Leader is the member with the highest score across all their picks in ENZN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
EMBitzy 60.14 11/5/2008 Outperform 3Y $4.96 +81.05% +10.77% +70.28
ArmChairQB < 20 10/14/2008 1/7/2009 Outperform 1Y $5.32 +68.80% +4.97% +63.83
ecabiac 82.56 10/8/2008 Outperform NS $5.31 +69.11% +12.89% +56.22
gerard240 < 20 8/14/2007 Outperform 3M $6.80 +32.06% -21.25% +53.31
codyevans916 < 20 5/11/2007 Outperform NS $8.21 +9.38% -24.64% +34.02
onering202 39.84 7/8/2008 Outperform 1Y $7.45 +20.54% -12.90% +33.44
Heidi782 75.04 7/16/2008 Outperform 1Y $7.24 +24.03% -9.20% +33.23
erabens 93.02 7/7/2008 Outperform 5Y $7.47 +20.21% -12.83% +33.05
mikehav < 20 5/16/2007 Outperform 1Y $8.37 +7.29% -24.90% +32.18
badgerzeke < 20 7/28/2008 Outperform NS $7.50 +19.73% -11.92% +31.66

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCarisandCo 78.62 12/10/2008 Outperform NS $5.77 +55.63% +21.66% +33.97
TrackOppenheimer 26.63 9/10/2008 Outperform NS $8.50 +5.65% -10.76% +16.41
TrackEveillard 89.92 9/30/2007 Outperform NS $8.81 +1.93% -26.44% +28.37 1 Comment
TrackIcahn 27.08 9/30/2007 Outperform NS $8.81 +1.93% -26.44% +28.37 3 Comments

Featured Broker Partners